0

542678

CHCL

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Cian Healthcare Limited Share Price Today

Investment Returns

Over 1 Month 0.00% Over 3 Months 62.27% Over 6 Months 51.83% Over 1 Year 164.74%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Cian Healthcare Limited fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 20.60
  • P/E Ratio (TTM) -1.05
  • Beta -0.64
  • Book Value / share 16.86
  • Return on equity 0.00%
  • EPS (TTM) 0.00
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.00
info icon alternate text

Cian Healthcare Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 28.30
Operating Expense 37.07
Net Profit -21.02
Net Profit Margin (%) -74.27
Earnings Per Share (EPS) -8.41
EBITDA -18.57
Effective Tax Rate (%) -0.52
Particulars MAR 2025 (Values in Cr)
Revenue 30.88
Operating Expense 38.56
Net Profit -19.66
Net Profit Margin (%) -63.66
Earnings Per Share (EPS) -7.86
EBITDA -15.02
Effective Tax Rate (%) 0.10
Particulars MAR 2024 (Values in Cr)
Revenue 58.75
Operating Expense 59.80
Net Profit 0.39
Net Profit Margin (%) 0.66
Earnings Per Share (EPS) 0.16
EBITDA 8.42
Effective Tax Rate (%) -3800.00
Particulars MAR 2023 (Values in Cr)
Revenue 67.56
Operating Expense 66.93
Net Profit 1.08
Net Profit Margin (%) 1.59
Earnings Per Share (EPS) 0.43
EBITDA 9.02
Effective Tax Rate (%) 10.00
Particulars MAR 2022 (Values in Cr)
Revenue 64.10
Operating Expense 66.88
Net Profit -2.28
Net Profit Margin (%) -3.55
Earnings Per Share (EPS) -0.91
EBITDA 5.33
Effective Tax Rate (%) 4.20
Particulars MAR 2025 (Values in Cr)
Book Value / Share 12.95
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.22
EBITDA Margin -20.48
Particulars MAR 2024 (Values in Cr)
Book Value / Share 23.34
ROE % 1.33
ROCE % 4.65
Total Debt to Total Equity 1.01
EBITDA Margin 18.67
Particulars MAR 2023 (Values in Cr)
Book Value / Share 23.00
ROE % 3.41
ROCE % 6.59
Total Debt to Total Equity 1.10
EBITDA Margin 20.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 22.19
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 1.18
EBITDA Margin 6.19
Particulars MAR 2021 (Values in Cr)
Book Value / Share 24.92
ROE % 0.12
ROCE % 6.61
Total Debt to Total Equity 1.23
EBITDA Margin 16.64
Particulars MAR 2025 (Values in Cr)
Book Value / Share 16.86
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.78
EBITDA Margin -8.61
Particulars MAR 2024 (Values in Cr)
Book Value / Share 24.73
ROE % 0.63
ROCE % 4.43
Total Debt to Total Equity 0.68
EBITDA Margin 14.67
Particulars MAR 2023 (Values in Cr)
Book Value / Share 24.57
ROE % 1.77
ROCE % 5.54
Total Debt to Total Equity 0.70
EBITDA Margin 14.25
Particulars MAR 2022 (Values in Cr)
Book Value / Share 24.14
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.77
EBITDA Margin 8.49
Particulars MAR 2021 (Values in Cr)
Book Value / Share 25.62
ROE % 0.69
ROCE % 6.51
Total Debt to Total Equity 0.84
EBITDA Margin 13.43
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 17.77
Total Assets 156.05
Total Liabilities 156.05
Total Equity 32.35
Share Outstanding 2
Price to Book Ratio 0.20
Return on Assets (%) -16.64
Return on Capital (%) -29.74
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.19
Total Assets 161.17
Total Liabilities 161.17
Total Equity 58.33
Share Outstanding 2
Price to Book Ratio 0.84
Return on Assets (%) 0.52
Return on Capital (%) 0.74
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.32
Total Assets 160.47
Total Liabilities 160.47
Total Equity 57.48
Share Outstanding 2
Price to Book Ratio 1.14
Return on Assets (%) 1.26
Return on Capital (%) 1.72
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.34
Total Assets 165.93
Total Liabilities 165.93
Total Equity 55.45
Share Outstanding 2
Price to Book Ratio 0.79
Return on Assets (%) -3.33
Return on Capital (%) -4.67
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.32
Total Assets 157.25
Total Liabilities 157.25
Total Equity 58.24
Share Outstanding 2
Price to Book Ratio 0.44
Return on Assets (%) 0.03
Return on Capital (%) 0.04
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 17.65
Total Assets 142.67
Total Liabilities 142.67
Total Equity 42.15
Share Outstanding 2
Price to Book Ratio 0.20
Return on Assets (%) -13.77
Return on Capital (%) -23.93
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.72
Total Assets 142.89
Total Liabilities 142.89
Total Equity 61.81
Share Outstanding 2
Price to Book Ratio 0.84
Return on Assets (%) 0.27
Return on Capital (%) 0.38
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.12
Total Assets 140.63
Total Liabilities 140.63
Total Equity 61.42
Share Outstanding 2
Price to Book Ratio 1.14
Return on Assets (%) 0.76
Return on Capital (%) 1.03
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.22
Total Assets 139.78
Total Liabilities 139.78
Total Equity 60.34
Share Outstanding 2
Price to Book Ratio 0.79
Return on Assets (%) -1.62
Return on Capital (%) -2.2
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.20
Total Assets 134.63
Total Liabilities 134.63
Total Equity 59.87
Share Outstanding 2
Price to Book Ratio 0.44
Return on Assets (%) 0.24
Return on Capital (%) 0.33
Particulars MAR 2025 (Values in Cr)
Net Income -25.97
Cash from Operations 20.75
Cash from Investing -0.25
Cash from Financing -3.92
Net change in Cash 16.57
Free Cash Flow 20.79
Particulars MAR 2024 (Values in Cr)
Net Income 0.84
Cash from Operations 11.76
Cash from Investing -1.45
Cash from Financing -10.44
Net change in Cash -0.13
Free Cash Flow 11.92
Particulars MAR 2023 (Values in Cr)
Net Income 2.02
Cash from Operations 4.84
Cash from Investing 2.55
Cash from Financing -7.40
Net change in Cash -0.01
Free Cash Flow 5.27
Particulars MAR 2022 (Values in Cr)
Net Income -5.53
Cash from Operations 8.57
Cash from Investing 1.39
Cash from Financing -10.95
Net change in Cash -0.98
Free Cash Flow 25.89
Particulars MAR 2021 (Values in Cr)
Net Income 0.05
Cash from Operations 5.93
Cash from Investing 2.71
Cash from Financing -9.77
Net change in Cash -1.12
Free Cash Flow 6.49
Particulars MAR 2025 (Values in Cr)
Net Income -19.65
Cash from Operations 20.65
Cash from Investing -0.26
Cash from Financing -3.45
Net change in Cash 16.92
Free Cash Flow 20.69
Particulars MAR 2024 (Values in Cr)
Net Income 0.38
Cash from Operations 6.94
Cash from Investing -0.92
Cash from Financing -6.41
Net change in Cash -0.39
Free Cash Flow 7.08
Particulars MAR 2023 (Values in Cr)
Net Income 1.07
Cash from Operations 2.15
Cash from Investing -1.08
Cash from Financing -1.16
Net change in Cash -0.09
Free Cash Flow 2.39
Particulars MAR 2022 (Values in Cr)
Net Income -2.27
Cash from Operations 5.50
Cash from Investing -3.84
Cash from Financing -2.64
Net change in Cash -0.98
Free Cash Flow 22.16
Particulars MAR 2021 (Values in Cr)
Net Income 0.32
Cash from Operations 5.46
Cash from Investing -1.20
Cash from Financing -5.06
Net change in Cash -0.80
Free Cash Flow 5.87
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 13.14 1.53 243.69 23.12 38.85
BLISS GVS PHARMA LTD. 486.60 39.50 4.32 5160.70 118.35 493.70
CIPLA LTD 1353.85 28.73 3.17 109370.14 1165.55 1672.20
FERMENTA BIOTECH LIMITED 338.20 14.92 2.44 995.36 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.80 22.24 4.09 243.69 23.12 38.85
AMRUTAJAN HEALTH LTD 546.70 24.50 4.26 1580.54 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8406.60 109.79 24.07 21016.50 7630.00 9850.00
BLISS GVS PHARMA LTD. 486.60 52.49 4.46 5160.70 118.35 493.70

Cian Healthcare Limited shareholding pattern

Holding
5.0%
95.0%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Cian Healthcare Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
8.26 4.95 redarrow
red-green-graph indicator
0 Bearish
0 Bullish
  • 5 Days 0.00
  • 26 Days 0.00
  • 10 Days 0.00
  • 50 Days 0.00
  • 12 Days 0.00
  • 100 Days 0.00
  • 20 Days 0.00
  • 200 Days 0.00
8.26 PIVOT
First Support 8.26 First Resistance 8.26 Second Support 8.26 Second Resistance 8.26 Third Support 8.26 Third Resistance 8.26
RSI 82.82 ADX 29.58 MACD 0.00 Williams % R 0.00 Commodity Channel Index (CCI) 339.40
Date 2026-01-20 Week 102000.00 Same Day 56000.00 Month 124700.00
1 Year -1.41 3 Year 0.50
Over 1 Month
0.00% down
Over 1 Year
164.74% down
Over 3 Months
62.27% down
Over 3 Years
-31.32% down
Over 6 Months
51.83% down
Over 5 Years
-5.56% down

Cian Healthcare Limited Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Cian Healthcare Ltd?

Answer Field

Cian Healthcare Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 8.26 as on Apr 10 2026 12:00 AM.

What is the Market Cap of Cian Healthcare Ltd Share?

Answer Field

The market cap of Cian Healthcare Ltd for NSE ₹ 0.00 & for BSE ₹ 20.60 as on Apr 10 2026 12:00 AM.

What is the 52 Week High and Low of Cian Healthcare Ltd?

Answer Field

The 52 Week High and Low of Cian Healthcare Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 8.26 and ₹ 3.11.

What is 1 year return for Cian Healthcare Ltd?

Answer Field

The 1 year returns on the stock has been 164.74%.

What is the P/E Ratio of Cian Healthcare Ltd Share?

Answer Field

As on Apr 10 2026 12:00 AM the price-to-earnings (PE) ratio for Cian Healthcare Ltd share is -1.05.

What is the PB ratio of Cian Healthcare Ltd Share?

Answer Field

As on Apr 10 2026 12:00 AM, the price-to-book (PB) ratio for Cian Healthcare Ltd share is 16.86.

How to Buy Cian Healthcare Ltd Share?

Answer Field

You can trade in Cian Healthcare Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Cian Healthcare Ltd Share on Bajaj Broking App?

Answer Field

To buy Cian Healthcare Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Cian Healthcare Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|